Personalized Escitalopram Dosing in Patients With Depression
Condition:   Depressive Disorder, Major Intervention:   Drug: Escitalopram Sponsors:   University of Belgrade;   Clinical Centre of Serbia;   Institute of Mental Health, Serbia;   Military Medical Academy, Belgrade, Serbia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2022 Category: Research Source Type: clinical trials

A Comparative Study on Efficacy and Safety of add-on Sulforaphane or rTMS to Escitalopram for Major Depressive Disorder With Poor Response to Initial Treatment
Condition:   Major Depressive Disorder Interventions:   Dietary Supplement: Escitalopram+Sulforaphane;   Device: Escitalopram+rTMS;   Drug: Escitalopram Sponsor:   Shanghai Mental Health Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2021 Category: Research Source Type: clinical trials